Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Finasteride effectively blocks enzyme causing male pattern baldness.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Finasteride may improve prostate cancer treatment outcomes.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Combination therapies work better than single treatments for hair loss.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.